Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.

During the last decade, significant scientific research efforts have led to a significant growth in understanding of cancer at the genetic, molecular, and cellular levels providing great opportunities for diagnosis and treatment of cancer diseases. The hopes for fast cancer diagnosis and treatment were significantly increased by the entrance of nanoparticles to the medical sciences. Nanoparticles are attractive due to their unique opportunities together with negligible side effects not only in cancer therapy but also in the treatment of other ailments. Among all types of nanoparticles, surface-engineered superparamagnetic iron oxide nanoparticles (SPIONs) have been attracted a great attention for cancer therapy applications. This review covers the recent advances in the development of SPIONs together with their opportunities and challenges, as theranosis agents, in cancer treatment.

[1]  S. Thakur,et al.  Emerging Implications of Nanotechnology on Cancer Diagnostics and Therapeutics , 2012 .

[2]  Brian D. MacCraith,et al.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications , 2011, Cellular and Molecular Life Sciences.

[3]  B. Rashidian,et al.  Raman active jagged-shaped gold-coated magnetic particles as a novel multimodal nanoprobe. , 2011, Chemical communications.

[4]  Qiao Jin,et al.  Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil. , 2011, Biomacromolecules.

[5]  Ick Chan Kwon,et al.  In vivo targeted delivery of nanoparticles for theranosis. , 2011, Accounts of chemical research.

[6]  Taeghwan Hyeon,et al.  Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. , 2011, Accounts of chemical research.

[7]  M. Pishko,et al.  Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies. , 2011, Biomacromolecules.

[8]  Morteza Mahmoudi,et al.  Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. , 2011, Advances in colloid and interface science.

[9]  Morteza Mahmoudi,et al.  Engineered nanoparticles for biomolecular imaging. , 2011, Nanoscale.

[10]  M. Siddique,et al.  Hydrothermal synthesis of alpha Fe2O3 nanoparticles capped by Tween-80 , 2011 .

[11]  M. A. Holgado,et al.  Possibilities of poly(D,L-lactide-co-glycolide) in the formulation of nanomedicines against cancer. , 2011, Current drug targets.

[12]  Xiaoling Zhang,et al.  Near-infrared light-responsive core-shell nanogels for targeted drug delivery. , 2011, ACS nano.

[13]  Omid C Farokhzad,et al.  Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. , 2011, Accounts of chemical research.

[14]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[15]  A. Milani,et al.  Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Surface Engineering, Cytotoxicity and Biomedical Applications , 2011 .

[16]  M. Sahraian,et al.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of multiple sclerosis. , 2011, ACS chemical neuroscience.

[17]  Morteza Mahmoudi,et al.  Effect of nanoparticles on the cell life cycle. , 2011, Chemical reviews.

[18]  M. Mahmoudi,et al.  Superparamagnetic colloidal nanocrystal clusters coated with polyethylene glycol fumarate: a possible novel theranostic agent. , 2011, Nanoscale.

[19]  Morteza Mahmoudi,et al.  Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. , 2011, Nanoscale.

[20]  U. Sharma,et al.  Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. , 2011, ACS applied materials & interfaces.

[21]  Paula T Hammond,et al.  Virtual issue on nanomaterials for drug delivery. , 2011, ACS nano.

[22]  Karthikeyan Subramani,et al.  Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. , 2011, Chemical reviews.

[23]  Jason Park,et al.  Modulation of CD4+ T lymphocyte lineage outcomes with targeted, nanoparticle-mediated cytokine delivery. , 2011, Molecular pharmaceutics.

[24]  Byung-Heon Lee,et al.  A novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumor. , 2011, Molecular pharmaceutics.

[25]  M. Mahmoudi,et al.  Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. , 2011, Advanced drug delivery reviews.

[26]  Duxin Sun,et al.  Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.

[27]  Dmitri Artemov,et al.  Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy. , 2010, ACS nano.

[28]  Peter Wust,et al.  Magnetic nanoparticle hyperthermia for prostate cancer , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[29]  Omid C Farokhzad,et al.  pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.

[30]  Nishanth Krishnamurthy,et al.  Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. , 2010, ACS nano.

[31]  P. Wust,et al.  Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme , 2010, Journal of Neuro-Oncology.

[32]  Yufang Zhu,et al.  Folate-Conjugated Fe3O4@SiO2 Hollow Mesoporous Spheres for Targeted Anticancer Drug Delivery , 2010 .

[33]  V. Grégoire,et al.  Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. , 2010, Contrast media & molecular imaging.

[34]  Carlos Rinaldi,et al.  Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells , 2010 .

[35]  S. Caruthers,et al.  Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles , 2010, Magnetic resonance in medicine.

[36]  M. O’Donnell,et al.  Multifunctional nanoparticles as coupled contrast agents. , 2010, Nature communications.

[37]  Y. Shieh,et al.  Magnetic chitosan/iron (II, III) oxide nanoparticles prepared by spray-drying , 2010 .

[38]  T. Jovin,et al.  Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. , 2010, Bioconjugate chemistry.

[39]  M. Mahmoudi,et al.  Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications , 2010 .

[40]  K. Landfester,et al.  The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. , 2010, Biomaterials.

[41]  Toshinobu Yogo,et al.  High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect. , 2010, ACS applied materials & interfaces.

[42]  Angela M Belcher,et al.  Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. , 2010, Nano letters.

[43]  A. Maharramov,et al.  A SYNTHETIC MACROMOLECULE AS MRI DETECTABLE DRUG CARRIERS: AMINODEXTRAN-COATED IRON OXIDE NANOPARTICLES , 2010 .

[44]  Chandana Mohanty,et al.  Dual drug loaded superparamagnetic iron oxide nanoparticles for targeted cancer therapy. , 2010, Biomaterials.

[45]  Sandeep Arora,et al.  Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. , 2010, Radiology.

[46]  Hao‐Li Zhang,et al.  Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. , 2010, Journal of nanoscience and nanotechnology.

[47]  M. Nakajo,et al.  Comparison of ferucarbotran‐enhanced fluid‐attenuated inversion‐recovery echo‐planar, T2‐weighted turbo spin‐echo, T2*‐weighted gradient‐echo, and diffusion‐weighted echo‐planar imaging for detection of malignant liver lesions , 2010, Journal of magnetic resonance imaging : JMRI.

[48]  V. Bulmus,et al.  The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications , 2010 .

[49]  Igor Pantic.  MAGNETIC NANOPARTICLES IN CANCER DIAGNOSIS AND TREATMENT: NOVEL APPROACHES , 2010 .

[50]  J. Lewis,et al.  Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.

[51]  M. Katsnelson,et al.  Ligand-controlled magnetic interactions in Mn(4) clusters. , 2009, Inorganic chemistry.

[52]  S. Laurent,et al.  Iron oxide based MR contrast agents: from chemistry to cell labeling. , 2009, Current medicinal chemistry.

[53]  Youichi Araki,et al.  Perfusion study of liver lesions with superparamagnetic iron oxide: distinguishing hepatocellular carcinoma from focal nodular hyperplasia. , 2009, Clinical imaging.

[54]  G. Belli,et al.  Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization? , 2009, Journal of magnetic resonance imaging : JMRI.

[55]  J. Greneche,et al.  Water soluble dendronized iron oxide nanoparticles. , 2009, Dalton transactions.

[56]  S. Mohapatra,et al.  Synthesis and stability of functionalized iron oxide nanoparticles using organophosphorus coupling agents , 2009 .

[57]  Maria Triantafyllou,et al.  Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. , 2009, European urology.

[58]  A. Elaissari,et al.  Aminodextran containing magnetite nanoparticles for molecular biology applications: preparation and evaluation. , 2009, Journal of biomedical nanotechnology.

[59]  Asako Narita,et al.  Facile control of silica shell layer thickness on hydrophilic iron oxide nanoparticles via reverse micelle method , 2009 .

[60]  Andrew D. Miller,et al.  Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging. , 2009, Bioconjugate chemistry.

[61]  Abbas S. Milani,et al.  Multiphysics Flow Modeling and in Vitro Toxicity of Iron Oxide Nanoparticles Coated with Poly(vinyl alcohol) , 2009 .

[62]  Gary Friedman,et al.  Magnetic targeting for site-specific drug delivery: applications and clinical potential. , 2009, Expert opinion on drug delivery.

[63]  R. Hong,et al.  Synthesis, characterization and MRI application of dextran-coated Fe3O4 magnetic nanoparticles , 2008 .

[64]  Prateek Singh,et al.  Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. , 2008, Bioconjugate chemistry.

[65]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[66]  Morteza Mahmoudi,et al.  Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging. , 2008, The journal of physical chemistry. B.

[67]  Bing Xu,et al.  Multifunctional yolk-shell nanoparticles: a potential MRI contrast and anticancer agent. , 2008, Journal of the American Chemical Society.

[68]  B. Aggarwal,et al.  Cancer is a Preventable Disease that Requires Major Lifestyle Changes , 2008, Pharmaceutical Research.

[69]  Wah Chiu,et al.  Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. , 2008, Journal of the American Chemical Society.

[70]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[71]  H. A. Therese,et al.  Fabrication of a Silica Coating on Magnetic γ-Fe2O3 Nanoparticles by an Immobilized Enzyme , 2008 .

[72]  T. Schmitz-Rode,et al.  Synthesis, physicochemical characterization and MR relaxometry of aqueous ferrofluids. , 2008, Journal of nanoscience and nanotechnology.

[73]  Yu Zhang,et al.  Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanoparticles via surface double-exchange with DMSA , 2008 .

[74]  T. Brown,et al.  Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. , 2008, ACS nano.

[75]  Donghoon Lee,et al.  In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.

[76]  I. Sauer,et al.  Tracking of Primary Human Hepatocytes with Clinical MRI: Initial Results with Tat-Peptide Modified Superparamagnetic Iron Oxide Particles , 2008, The International journal of artificial organs.

[77]  K. Jun,et al.  Nonaqueous synthesis and characterization of capped α-Fe2O3 nanoparticles from iron(III) hydroxy-oleate precursor , 2008 .

[78]  B. Hamm,et al.  Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis. , 2008, Small.

[79]  A. Jordan,et al.  Clinical applications of magnetic nanoparticles for hyperthermia , 2008, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[80]  Dean-Mo Liu,et al.  Magnetic-sensitive silica nanospheres for controlled drug release. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[81]  Peter Wust,et al.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. , 2007, European urology.

[82]  A. Jordan,et al.  Magnetic nanoparticles for intracranial thermotherapy. , 2007, Journal of nanoscience and nanotechnology.

[83]  B. Rau,et al.  Thermotherapie mit magnetischen Nanopartikeln , 2007, Der Onkologe.

[84]  Sang Bok Lee,et al.  Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. , 2007, Drug discovery today.

[85]  G. Cagney,et al.  Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. , 2007, Angewandte Chemie.

[86]  S. Loening,et al.  [Thermal therapy of prostate cancer using magnetic nanoparticles]. , 2007, Actas urologicas espanolas.

[87]  Robert Ivkov,et al.  Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy , 2007 .

[88]  S. Dutz,et al.  Magnetic particle hyperthermia—biophysical limitations of a visionary tumour therapy , 2007 .

[89]  E. E. Carpenter,et al.  Enhanced ferrite nanoparticles as MRI contrast agents , 2007 .

[90]  E. Lukevics,,et al.  Synthesis and characterization of nanoparticles with an iron oxide magnetic core and a biologically active trialkylsilylated aliphatic alkanolamine shell , 2007 .

[91]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[92]  A. Lu,et al.  Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.

[93]  P Wust,et al.  Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial , 2007, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[94]  P. Wust,et al.  Thermotherapy using magnetic nanoparticles , 2007 .

[95]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[96]  D. Creanga,et al.  Citric-acid-coated magnetite nanoparticles for biological applications , 2006, The European physical journal. E, Soft matter.

[97]  K. Neoh,et al.  Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. , 2006, Biomaterials.

[98]  Hua Ai,et al.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.

[99]  R. Weissleder,et al.  Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.

[100]  Miqin Zhang,et al.  Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. , 2006, Journal of biomedical materials research. Part A.

[101]  Jeremiah A. Johnson,et al.  Toward the Syntheses of Universal Ligands for Metal Oxide Surfaces: Controlling Surface Functionality through Click Chemistry , 2006 .

[102]  You Qiang,et al.  Iron/iron oxide core-shell nanoclusters for biomedical applications , 2006 .

[103]  Hirokazu Miyoshi,et al.  Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[104]  T. Ihalainen,et al.  Magnetic resonance imaging of viral particle biodistribution in vivo , 2006, Gene Therapy.

[105]  H. Bruhn,et al.  Local Arterial Infusion of Superparamagnetic Iron Oxide Particles in Hepatocellular Carcinoma: A Feasibility and 3.0 T MRI Study , 2006, Investigative radiology.

[106]  R. Weissleder,et al.  Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. , 2006, Bioconjugate chemistry.

[107]  Ralph Weissleder,et al.  “Clickable” Nanoparticles for Targeted Imaging , 2006, Molecular imaging.

[108]  Paula M Jacobs,et al.  Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent , 2006, Investigative radiology.

[109]  R. Langer,et al.  Investigation of targeting mechanism of new dextran-peptide-methotrexate conjugates using biodistribution study in matrix-metalloproteinase-overexpressing tumor xenograft model. , 2006, Journal of pharmaceutical sciences.

[110]  Carola Leuschner,et al.  Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases. , 2006, Biomaterials.

[111]  S. A. Gómez-Lopera,et al.  Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[112]  C. Allen,et al.  Epidermal growth factor-conjugated poly(ethylene glycol)-block- poly(delta-valerolactone) copolymer micelles for targeted delivery of chemotherapeutics. , 2006, Bioconjugate chemistry.

[113]  S. Gubin,et al.  Magnetic Nanoparticles Preparation, Structure and Properties , 2006 .

[114]  Jens Ricke,et al.  Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[115]  S. Loening,et al.  Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer , 2006, The Prostate.

[116]  Peter Wust,et al.  Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.

[117]  R. Weissleder,et al.  Development of nanoparticle libraries for biosensing. , 2006, Bioconjugate chemistry.

[118]  Roland Felix,et al.  The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma , 2006, Journal of Neuro-Oncology.

[119]  S. Goodman,et al.  Titanium Implant Materials with Improved Biocompatibility through Coating with Phosphonate‐Anchored Cyclic RGD Peptides , 2005, Chembiochem : a European journal of chemical biology.

[120]  P Wust,et al.  Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique , 2005, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[121]  Francesco M Veronese,et al.  PEGylation, successful approach to drug delivery. , 2005, Drug discovery today.

[122]  G. Grundmeier,et al.  Spectroscopic analysis of the interface chemistry of ultra-thin plasma polymer films on iron , 2005 .

[123]  Bobbi K Lewis,et al.  A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging , 2005, NMR in biomedicine.

[124]  Jin-Sil Choi,et al.  In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.

[125]  Qing Peng,et al.  A general strategy for nanocrystal synthesis , 2005, Nature.

[126]  J. Duerk,et al.  Magnetite‐Loaded Polymeric Micelles as Ultrasensitive Magnetic‐Resonance Probes , 2005 .

[127]  Klaus Jung,et al.  Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model , 2005, The Prostate.

[128]  Z. Rosenzweig,et al.  Manipulation of the magnetic properties of magnetite-silica nanocomposite materials by controlled Stober synthesis. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[129]  T. Nishimura,et al.  Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma , 2005, British Journal of Cancer.

[130]  S. A. Gómez-Lopera,et al.  Loading of 5-Fluorouracil to Poly(ethyl-2-cyanoacrylate) Nanoparticles with a Magnetic Core , 2005 .

[131]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[132]  Etienne Duguet,et al.  A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran , 2005 .

[133]  E. Kim,et al.  Synthesis of SPIO-chitosan microspheres for MRI-detectable embolotherapy , 2005 .

[134]  C. Serna,et al.  Surface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitation , 2005 .

[135]  R. Weissleder,et al.  In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. , 2005, Bioconjugate chemistry.

[136]  Mingyuan Gao,et al.  One‐Pot Reaction to Synthesize Biocompatible Magnetite Nanoparticles , 2005 .

[137]  G. Whitesides,et al.  Self-assembled monolayers of thiolates on metals as a form of nanotechnology. , 2005, Chemical reviews.

[138]  Yong Zhang,et al.  Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells. , 2005, Journal of colloid and interface science.

[139]  Samir Mitragotri,et al.  Healing sound: the use of ultrasound in drug delivery and other therapeutic applications , 2005, Nature Reviews Drug Discovery.

[140]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[141]  Younan Xia,et al.  Synthesis and characterization of monodisperse silica colloids loaded with superparamagnetic iron oxide nanoparticles , 2005 .

[142]  Taeghwan Hyeon,et al.  Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.

[143]  Kevin M Brindle,et al.  Detection of apoptosis using the C2A domain of synaptotagmin I. , 2004, Bioconjugate chemistry.

[144]  Bing Xu,et al.  Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. , 2004, Journal of the American Chemical Society.

[145]  U. Häfeli,et al.  Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy , 2004 .

[146]  E. Groman,et al.  Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. , 2004, Bioconjugate chemistry.

[147]  Ming Yang,et al.  Integrated microsystems for controlled drug delivery. , 2004, Advanced drug delivery reviews.

[148]  S. Mitragotri,et al.  Current status and future potential of transdermal drug delivery , 2004, Nature Reviews Drug Discovery.

[149]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[150]  J. Gallo,et al.  Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats , 2004, Journal of Neuro-Oncology.

[151]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[152]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[153]  Yu Zhang,et al.  Starch-Coated Superparamagnetic Nanoparticles as MR Contrast Agents , 2003 .

[154]  Robert Langer,et al.  Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.

[155]  Q. Pankhurst,et al.  TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine , 2003 .

[156]  Afsaneh Lavasanifar,et al.  Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.

[157]  M. Markman.  Intraperitoneal antineoplastic drug delivery: rationale and results. , 2003, The Lancet. Oncology.

[158]  Vladimir P Torchilin,et al.  Peptide and protein drug delivery to and into tumors: challenges and solutions. , 2003, Drug discovery today.

[159]  Dmitri Artemov,et al.  MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.

[160]  L. Illum.  Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[161]  Catherine C. Berry,et al.  Functionalisation of magnetic nanoparticles for applications in biomedicine : Biomedical applications of magnetic nanoparticles , 2003 .

[162]  L. Illum.  Nasal drug delivery: new developments and strategies. , 2002, Drug discovery today.

[163]  Erkki Ruoslahti,et al.  Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[164]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[165]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[166]  Yang Liu,et al.  Therapeutic ultrasound: Its application in drug delivery , 2002, Medicinal research reviews.

[167]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[168]  P. Moroz,et al.  Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[169]  K. Yao,et al.  Preparation of oxidized glucose-crosslinked N-alkylated chitosan membrane and in vitro studies of pH-sensitive drug delivery behaviour. , 2002, Biomaterials.

[170]  Kinam Park,et al.  Environment-sensitive hydrogels for drug delivery , 2001 .

[171]  H. Klok,et al.  Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. , 2001, Advanced drug delivery reviews.

[172]  Laigui Yu,et al.  Preparation and characterization of self-assembled alkanephosphate monolayers on glass substrate coated with nano-TiO2 thin film , 2001 .

[173]  H. Pizem,et al.  Alkyl Phosphonate/Phosphate Coating on Magnetite Nanoparticles: A Comparison with Fatty Acids , 2001 .

[174]  Ming Zhao,et al.  Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.

[175]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[176]  R Weissleder,et al.  Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. , 2001, Journal of immunological methods.

[177]  A. Bjørnerud,et al.  A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.

[178]  S. Goodwin,et al.  Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[179]  T. A. Hatton,et al.  Structure of Alkanoic Acid Stabilized Magnetic Fluids. A Small-Angle Neutron and Light Scattering Analysis , 2001 .

[180]  T. Murakami,et al.  Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters. , 2001, International journal of oncology.

[181]  C. Alexiou,et al.  Locoregional cancer treatment with magnetic drug targeting. , 2000, Cancer research.

[182]  T. Murakami,et al.  Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters. , 2000, International journal of oncology.

[183]  C. Beigelman,et al.  Iron oxide-enhanced MR lymphography: initial experience. , 2000, European journal of radiology.

[184]  J A Frank,et al.  Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[185]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[186]  Carl K. Hoh,et al.  Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .

[187]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[188]  J. Bulte,et al.  Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .

[189]  Peter Wust,et al.  Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .

[190]  Loftssona,et al.  Cyclodextrins in ophthalmic drug delivery. , 1999, Advanced drug delivery reviews.

[191]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[192]  B. Chu,et al.  Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles , 1999 .

[193]  M. Cima,et al.  A controlled-release microchip , 1999, Nature.

[194]  Henry,et al.  Microfabricated microneedles: A novel approach to transdermal drug delivery , 1999, Journal of pharmaceutical sciences.

[195]  W. Kaiser,et al.  Physical limits of hyperthermia using magnetite fine particles , 1998 .

[196]  W Semmler,et al.  Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathways , 1998, Magnetic resonance in medicine.

[197]  Nathalie Siauve,et al.  Liver Imaging With Ferumoxides (Feridex®): Fundamentals, Controversies, and Practical Aspects , 1998, Topics in magnetic resonance imaging : TMRI.

[198]  J. Bacri,et al.  Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.

[199]  P. Sado,et al.  Ophthalmic drug delivery systems—Recent advances , 1998, Progress in Retinal and Eye Research.

[200]  J. Gallo,et al.  Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres. , 1998, Journal of drug targeting.

[201]  C. Marx,et al.  SPIO‐enhanced 2D‐TOF MR angiography of the portal venous system: Results of an intraindividual comparison , 1997, Journal of magnetic resonance imaging : JMRI.

[202]  A. Bée,et al.  Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid , 1997, Journal of colloid and interface science.

[203]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[204]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[205]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[206]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[207]  D. Huhn,et al.  Preclinical experiences with magnetic drug targeting: tolerance and efficacy. , 1996, Cancer research.

[208]  T. Egan,et al.  Intravenous drug delivery systems: toward an intravenous "vaporizer". , 1996, Journal of clinical anesthesia.

[209]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[210]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[211]  J M Gallo,et al.  Preparation and in vitro evaluation of magnetic microsphere-methotrexate conjugate drug delivery systems. , 1995, Bioconjugate chemistry.

[212]  C. W. Jung.  Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[213]  R Weissleder,et al.  Determinants of in vivo MR imaging of slow axonal transport. , 1994, Radiology.

[214]  R. Lufkin,et al.  Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. , 1994, AJNR. American journal of neuroradiology.

[215]  J. Weaver,et al.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[216]  L. Brannon-Peppas.  Novel vaginal drug release applications , 1993 .

[217]  S. Margel,et al.  Synthesis and characterization of self-assembled hydrophobic monolayer coatings on silica colloids , 1993 .

[218]  P. Bunn,et al.  Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .

[219]  K. Go,et al.  Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain. , 1993, European journal of radiology.

[220]  P. Wust,et al.  Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. , 1993, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[221]  A. Fischman,et al.  Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.

[222]  R. Feeney,et al.  Chemical Modifications of Proteins: History and Applications , 1990 .

[223]  J M Collins,et al.  Pharmacologic rationale for regional drug delivery. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[224]  K. Widder,et al.  Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. , 1983, European journal of cancer & clinical oncology.

[225]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[226]  K. Widder,et al.  In vivo kinetics of magnetically targeted low-dose doxorubicin. , 1981, Journal of pharmaceutical sciences.

[227]  K. Widder,et al.  Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[228]  K. Widder,et al.  Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. , 1979, Advances in pharmacology and chemotherapy.